Description
KLOW is a composite formulation of GHK-Cu, BPC-157, and TB-500 and KPV, designed for in-vitro investigations into coordinated metabolic signaling, cellular repair pathways, and inflammation-modulating biology.
GHK-Cu (glycyl-L-histidyl-L-lysine–copper) is studied for interactions with extracellular matrix dynamics, collagen synthesis, and antioxidant signaling; its cardiolipin-adjacent copper handling is of interest for redox balance and tissue remodeling.
TB-500 (thymosin-beta-4 fragment) is researched for its roles in actin-binding protein regulation, cell migration, angiogenesis, and support of cytoskeletal organization under mechanical or oxidative stress.
KPV (Lys-Pro-Val), a melanocortin-derived tripeptide, is researched for its potential to modulate inflammatory cascades and epithelial barrier responses.
Together, the trio allows researchers to probe metabolic regulation, redox balance, inflammation resolution, and cellular-repair cues within the same system—useful for metabolic, soft-tissue, and barrier-function testbeds. This blend is supplied for in-vitro laboratory and analytical use only and is not approved for clinical, human, or veterinary applications.
Reviews
There are no reviews yet.